Compare radiation types and surgery for pelvic bone sarcomas
Part of Bones, joints & muscles, Cancer clinical trials.
This study compares three treatment approaches—carbon ion radiation, proton radiation, and surgery—for sarcomas in the pelvis that involve bone. It looks to see which option best controls the tumor while helping protect nearby tissues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 15 or older
- Your cancer is newly diagnosed and confirmed by a tissue test (biopsy)
- Your tumor is in the pelvis and involves bone (or nearby soft tissue in specific listed sarcoma types)
- Your scans and exams show no spread to distant parts of the body
- You can do daily activities at a moderate level (ECOG 0 to 2)
- If you could become pregnant, you must use reliable birth control, and you must not be pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two standard treatment approaches—surgery versus definitive radiation—for people with a primary sacral chordoma (a bone tumor at the lower spine/pelvis area). It aims to find which approach works best for controlling the tumor while considering treatment side effects.
This trial is testing a precise type of radiation therapy (called SBRT) for people with sarcoma in the belly or pelvic area. The goal is to see if this targeted radiation can help shrink or control the tumor before surgery, and it may be an option if you haven't had radiation to that area before.
This trial tests a shorter, 3-week course of radiation therapy (using protons or standard X-rays) given before surgery for localized soft tissue sarcoma. It aims to see if this approach is safe and effective for treating the tumor while reducing side effects.
This trial tests giving radiation therapy before surgery to treat Ewing sarcoma, a bone cancer that's hard to remove completely. The goal is to shrink the tumor first, then remove it surgically, to improve outcomes for patients with high-risk disease.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
Hear when a new Bone Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.